Caris Life Sciences Revenue and Competitors

Dallas, TX USA

Location

$1.3B

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Caris Life Sciences's estimated annual revenue is currently $426.1M per year.(i)
  • Caris Life Sciences received $150.0M in venture funding in October 2018.
  • Caris Life Sciences's estimated revenue per employee is $248,000
  • Caris Life Sciences's total funding is $1.3B.
  • Caris Life Sciences's current valuation is $7.8B.

Employee Data

  • Caris Life Sciences has 1718 Employees.(i)
  • Caris Life Sciences grew their employee count by 4% last year.

Caris Life Sciences's People

NameTitleEmail/Phone
1
US Head - VP Commercial SalesReveal Email/Phone
2
VP, Clinical and Translational ResearchReveal Email/Phone
3
Head - Strategic CollaborationsReveal Email/Phone
4
VP Clinical ProgramsReveal Email/Phone
5
VP, National AccountsReveal Email/Phone
6
SVP Human ResourcesReveal Email/Phone
7
VP Research DevelopmentReveal Email/Phone
8
VP - Associate General Counsel, IPReveal Email/Phone
9
VP ReimbursementReveal Email/Phone
10
Vice ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Caris Life Sciences?

Caris Life Sciences was founded because of an idea that personalized and precise information can improve healthcare for everyone. This idea drives everything we do at Caris Life Sciences. Caris combines the rigor of an academic medical institution with the innovative spirit of a technology company. We believe that innovative, high-quality testing and information can lead to more effective treatment selection and ultimately to better outcomes for patients with cancer and other complex diseases.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

$1.3B

Total Funding

1718

Number of Employees

$426.1M

Revenue (est)

4%

Employee Growth %

$7.8B

Valuation

N/A

Accelerator

Caris Life Sciences News

2022-04-13 - Caris' Precision Oncology Alliance Welcomes The University ...

Caris Life Sciences® (Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions to...

2022-04-13 - In Brief This Week: Illumina, Caris Life Sciences, Fresenius ...

Caris Life Sciences said this week that the University of Kentucky Markey Cancer Center has joined Caris' Precision Oncology Alliance,...

2022-03-22 - Zentalis Pharmaceuticals and Caris Life Sciences Announce ...

Caris Life Sciences® (Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions...

2021-06-04 - New Research from Caris Life Sciences Finds Immunotherapy Resistance in Leiomyosarcoma

IRVING, Texas, June 4, 2021 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, to present findings that provide a deeper understanding of how immunotherapies (IO) affect leiomyosarc ...

2021-05-12 - Caris Life Sciences scores $830M to grow AI-powered genetic sequencing platform Remarque Systems: Content Hub

For most medtech startups, the dream of raising a billion dollars is nothing but a castle in the air. Caris Life Sciences, meanwhile, just made itself at home in that castle after surpassing the 10-figure mark over the course of two funding rounds barely six months apart. Webinar Accelerating m ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$555M17645%$1M
#2
$300M1809N/AN/A
#3
$700.2M196917%N/A
#4
$414.9M2044N/AN/A
#5
$1014.6M215427%N/A

Caris Life Sciences Funding

DateAmountRoundLead InvestorsReference
2005-05-27$120.0MUndisclosedCaris LtdArticle
2018-10-02$150.0MUndisclosedTPG Sixth Street PartnersArticle